-
C126650-100mgProduct Description:CVT-313 is a potent CDK2 inhibitor with an IC50 of 0.5 microM in vitro. It has no effect on other, nonrelated ATP-dependent serine/threonine kinases.
-
C126650-10mgProduct Description:CVT-313 is a potent CDK2 inhibitor with an IC50 of 0.5 microM in vitro. It has no effect on other, nonrelated ATP-dependent serine/threonine kinases.
-
C126650-25mgProduct Description:CVT-313 is a potent CDK2 inhibitor with an IC50 of 0.5 microM in vitro. It has no effect on other, nonrelated ATP-dependent serine/threonine kinases.
-
C126650-50mgProduct Description:CVT-313 is a potent CDK2 inhibitor with an IC50 of 0.5 microM in vitro. It has no effect on other, nonrelated ATP-dependent serine/threonine kinases.
-
C126650-5mgProduct Description:CVT-313 is a potent CDK2 inhibitor with an IC50 of 0.5 microM in vitro. It has no effect on other, nonrelated ATP-dependent serine/threonine kinases.
-
-
-
C287317-10mgproduct description:CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.
-
C287317-1gproduct description:CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.
-
C287317-250mgproduct description:CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.
-
C287317-50mgproduct description:CX614 is a positive allosteric modulator of the AMPA receptor concerning AMPA.
-
C127975-10mgCX-4945 (Silmitasertib) is a potent and selective inhibitor of CK2 (casein kinase 2) with IC50 of 1 nM in a cell-free assay, less potent to Flt3, Pim1 and CDK1 (inactive in cell-based assay).An ATP-competitive CK2 protein kinase inhibitor.